Morgan Stanley analyst Robert Davies lowered the firm’s price target on Medacta Group to CHF 107 from CHF 109 and keeps an Overweight rating on the shares.
Published first on TheFly
Morgan Stanley analyst Robert Davies lowered the firm’s price target on Medacta Group to CHF 107 from CHF 109 and keeps an Overweight rating on the shares.
Published first on TheFly